Medicines losing patent protection

MonthYear

July 2026

6 medicines lost their last listed patent or exclusivity in July 2026.

Jul 1Fycompa · Tablet (oral)perampanel · Catalyst Pharmaceuticals Inc
Jul 1Fycompa · Suspension (oral)perampanel · Catalyst Pharmaceuticals Inc
Jul 13Opillnorgestrel · Laboratoire Hra Pharma
Jul 19Spirivatiotropium bromide · Boehringer Ingelheim Pharmaceuticals Inc
Jul 24Aktenlidocaine hydrochloride · Thea Pharma Inc
Jul 30Omegavenfish oil triglycerides · Fresenius Kabi USA LLC

Dates are the patent and exclusivity end dates listed in the FDA's Orange Book, in its data up to October 9, 2026. Patents can be extended, challenged in court or settled, so a generic may come earlier, later or not at all. This is not legal or medical advice.

About the data·Privacy·Credits